STOCK TITAN

Goldman Sachs (NASDAQ: TDAC) reports 6.1% position in TDAC

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Translational Development Acquisition Corp. disclosure: The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly report shared voting and dispositive power over 1,054,120 Class A ordinary shares (CUSIP G9008W105), representing 6.1% of the class as shown on the cover page. The filing includes a Joint Filing Agreement and exhibits clarifying that the holdings are reported by Goldman Sachs reporting units and that Goldman Sachs & Co. LLC is a subsidiary of GS Group. The signature block shows the filing was executed on 05/07/2026.

Positive

  • None.

Negative

  • None.

Insights

Goldman Sachs reports a 6.1% position in TDAC via shared voting/dispositive power.

The schedule shows 1,054,120 shares of Class A ordinary shares (CUSIP G9008W105) tied to Goldman Sachs reporting units. The filing is a joint statement executed under a Joint Filing Agreement and includes exhibits identifying the reporting subsidiary relationships.

Ownership is reported as shared voting and dispositive power; the filing disclaims beneficial ownership for client accounts per the cited Release. Timing and cash‑flow treatment are not detailed in the excerpt; subsequent filings would state any transactions or changes.

Shares with shared power 1,054,120 shares shared voting and dispositive power (cover page)
Percent of class 6.1% percent of Class A ordinary shares (cover page)
Par value $0.0001/share Class A ordinary shares par value
CUSIP G9008W105 identifier for the Class A ordinary shares
Execution date 05/07/2026 signature date on joint filing agreement and signatures
Cover page date 03/31/2026 date appearing near cover information
Schedule 13G regulatory
"Item 1. (a) Name of issuer: TRANSLATIONAL DEVELOPMENT ACQUISITION CORP."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
shared voting power regulatory
"Shared Voting Power 1,054,120.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Joint Filing Agreement regulatory
"EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)"
beneficially owned financial
"Item 4. Ownership (a) Amount beneficially owned: See the response(s) to Item 9"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.





G9008W105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



THE GOLDMAN SACHS GROUP, INC.
Signature:Name: Veronica Mupazviriwo
Name/Title:Attorney-in-fact
Date:05/07/2026
GOLDMAN SACHS & CO. LLC
Signature:Name: Veronica Mupazviriwo
Name/Title:Attorney-in-fact
Date:05/07/2026
Exhibit Information

EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Class A ordinary shares, $0.0001 par value per share, of TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: 05/07/2026 THE GOLDMAN SACHS GROUP, INC. By:/s/ Veronica Mupazviriwo ---------------------------------------- Name: Veronica Mupazviriwo Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ Veronica Mupazviriwo ---------------------------------------- Name: Veronica Mupazviriwo Title: Attorney-in-fact EXHIBIT (99.2) ITEM 7 INFORMATION The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company, are owned, or may be deemed to be beneficially owned, by Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs is a subsidiary of GS Group. EXHIBIT (99.3) ITEM 4 INFORMATION *In accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned by certain operating units (collectively, the "Goldman Sachs Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and affiliates (collectively, "GSG"). This filing does not reflect securities, if any, beneficially owned by any operating units of GSG whose ownership of securities is disaggregated from that of the Goldman Sachs Reporting Units in accordance with the Release. The Goldman Sachs Reporting Units disclaim beneficial ownership of the securities beneficially owned by (i) any client accounts with respect to which the Goldman Sachs Reporting Units or their employees have voting or investment discretion or both, or with respect to which there are limits on their voting or investment authority or both and (ii) certain investment entities of which the Goldman Sachs Reporting Units act as the general partner, managing general partner or other manager, to the extent interests in such entities are held by persons other than the Goldman Sachs Reporting Units.

FAQ

What stake does Goldman Sachs report in TDAC (TDAC)?

Goldman Sachs reports shared voting and dispositive power over 1,054,120 shares, which the cover page shows as 6.1% of TDAC's Class A ordinary shares. The amount and percentage are taken from the filing's cover-page entries.

Who filed the Schedule 13G for TDAC?

The filing was made jointly by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC under a Joint Filing Agreement signed on 05/07/2026, as stated in the exhibits and signature block.

Does the filing show sole control over the reported TDAC shares?

No. The filing lists 0 shares of sole voting or dispositive power and shows 1,054,120 shares of shared voting and dispositive power, indicating shared control among reporting units.

Are the reported TDAC shares owned directly by Goldman Sachs or client accounts?

The exhibits state the filing reflects securities owned by Goldman Sachs Reporting Units and expressly disclaim beneficial ownership for certain client accounts and disaggregated operating units, per the cited Release language.

What identifier and share class are reported for TDAC?

The filing covers Class A ordinary shares of Translational Development Acquisition Corp., CUSIP G9008W105, with a par value of $0.0001 per share, as shown in the cover information.